BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 921765)

  • 1. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides.
    Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC
    Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of biologically active retroenantiomers of angiotensin peptides.
    Goissis G; Nouaihetas VL; Paiva AC
    J Med Chem; 1976 Nov; 19(11):1287-90. PubMed ID: 1003405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidogenic and pressor activity of angiotensin analogues in the rat.
    Khairallah PA; Khosla MC; Bumpus FM; Tait JF; Tait SA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():175s-177s. PubMed ID: 282047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachyphylaxis and angiotensin receptors.
    Paiva TB; Aboulafia J; Nouailhetas VL; Paiva AC
    Gen Pharmacol; 1976 Aug; 7(2-3):185-8. PubMed ID: 185119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of paired analogs of angiotensin II and angiotensin III on rat smooth muscle.
    Moore GJ; Ko EM
    Pharmacology; 1980; 20(1):36-41. PubMed ID: 7375500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues.
    Nakaie CR; Oshiro ME; Goissis G; Paiva AC
    Biochim Biophys Acta; 1977 Nov; 495(1):151-8. PubMed ID: 20979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and specific pressor activity of [1-aspartic acid,5-valine,9-serine]angiotensin I ("fowl angiotensin I").
    Hayashi Y; Nakajima T; Watanabe TX; Sokabe H; Khosla MC; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):315-6. PubMed ID: 836506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for angiotensin tachyphylaxis in smooth muscles.
    Paiva TB; Miyamoto ME; Juliano L; Paiva AC
    J Pharmacol Exp Ther; 1977 Aug; 202(2):294-300. PubMed ID: 886468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of the two N-terminal residues of angiotensin II in the production of tachyphylaxis.
    Miasiro N; Oshiro ME; Paiva TB; Paiva AC
    Eur J Pharmacol; 1983 Mar; 87(4):397-406. PubMed ID: 6852096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II.
    Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC
    J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
    Paiva TB; Paiva AC; Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative pharmacology of new specific angiotensin antagonists.
    Schoelkens BA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and analysis of cyclic analogs of angiotensin].
    Antsans IuE; Bisenietse DA; Vosekalna IA; Myshliakova NV; Chipens GI
    Bioorg Khim; 1990 Mar; 16(3):358-69. PubMed ID: 2357239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
    Hagiwara M; Ohuchi E; Hongo K; Oki M; Wada K; Morikawa T; Kobashi K
    Jpn J Pharmacol; 1990 Mar; 52(3):493-5. PubMed ID: 2332941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.